Vaccination rates against coronavirus disease 2019 (COVID-19) are significantly lower in Black Americans compared with White Americans; spotlighting the impact of the pandemic on children with mental illness; a rapid blood test predicts which patients with COVID-19 are at highest risk of severe complications or death.
According to an article by Kaiser Health News, vaccination rates against coronavirus disease 2019 (COVID-19) have been shown to be significantly lower in Black Americans compared with White Americans. In 16 states, the vaccination rates have been shown to be 2 to 3 times higher in White Americans, while rates of COVID-19 mortality are nearly 3 times greater in Black, Hispanic, and Native Americans. Notably, issues with access to and mistrust of the vaccine were major factors linked with lower vaccination rates among Black Americans.
In an article by NPR, the impact of the COVID-19 pandemic on children with mental illness was spotlighted. For nearly 3 million children nationwide diagnosed with a serious emotional or behavioral health condition, trained teachers and therapists who understand their needs were largely separated from these students when schools closed last April. From April to October 2020, US hospitals saw a 24% increase in the proportion of mental health emergency visits for children aged 5 to 11 years, and a 31% increase for children aged 12 to 17 years.
A novel rapid blood test was found to predict which patients with COVID-19 are at highest risk of severe complications or death, according to a study by Washington University School of Medicine in St. Louis. The predictions, which come within a day of hospital admission, are based on levels of mitochondrial DNA, a unique type of DNA molecule that typically resides inside the energy factories of cells and was shown to spill out of cells and into the bloodstream as a sign of violent cell death in the body.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More